CTAG1B and ovarian carcinoma: The 2017 Schuster study also showed that NY-ESO-1 peptide antigen was not presented by MHC-I or MHC-II molecules in any of 42 epithelial ovarian cancer samples, although peptides from various MAGEA family members were presented [30].